Sort by: Article Title Contributor Topic Date

How Much Does The Average CEO Really Earn?

Hint: it’s a lot less than what mainstream media reports imply. Of the roughly 30 million businesses in the United States, less than 6,000 are publicly traded on major stock exchanges. As anyone who gets his or her information from mainstream news and media outlets well knows, the spotlight and analysis for business (especially in regard to CEO compensation) are firmly focused on S&P 500 companies. That means that virtually 100 percent of media coverage of CEO compensation focuses on less than 8 percent of all public companies and less than .002 percent of all companies in the U.S.

Michael Bamberger CEO Briefing Newsletter , CEO Compensation November 16 2012

How to Avoid the Seven Sins of Customer Experience

Customer experience can ultimately be an organization’s primary competitive advantage, if it is managed correctly. Exceptional customer service produces loyal customers who buy more, refer friends, resist special offers from competitors and forgive the occasional mistake. A new research report on customer experience sheds new light on the “seven sins” of customer experience — key missteps that make organizations stumble when it comes to customer interaction.

Sharon Daniels CEO Briefing Newsletter , Leadership & Strategy April 18 2013

Employee Engagement is the Key to Execution

Susan Scott, founder of the leadership development and training firm Fierce, writes for Chief Executive Online about the necessity of [...]

Ceo Briefing - April 7 2011 CEO Briefing Newsletter April 6 2011

Controlling Health Care Costs

Pockets where breakthrough successes have occurred suggest there are ways to contain the spiraling cost of health care.

Jennifer Pellet CEO Briefing Newsletter , Governance/Compliance , Leadership & Strategy January 25 2013

A Better Way to Build

Ann Hand, CEO of Project Frog, wants to “democratize” high-functioning buildings—delivering high-end design at value prices through pre-fab construction.

Jennifer Pellet CEO Briefing Newsletter , CEO Interviews February 1 2013

Case Study: Partnering for Potential, Array BioPharma’s Ron Squarer

You’ve stepped in as CEO at a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs used to treat cancer and inflammatory diseases. In taking the helm, you’re charged with finishing the company’s 10-year transition from developing drugs for larger pharma companies to steering some of those molecules through late-stage development and commercialization on its own.

Jennifer Pellet CEO Briefing Newsletter March 12 2013

Swisse Vitamin’s Radek Sali: The Natural

An Australian CEO shares his strategy for translating his marketing juggernaut’s success stateside.

Jennifer Pellet CEO Briefing Newsletter March 15 2013

Medifast’s Michael MacDonald: All in the Family

How a 33-year Xerox veteran made good at his ailing brother’s diet food company.

Jennifer Pellet CEO Briefing Newsletter May 24 2013

Rytec’s Don Grasso: Vertical Man

An investment banker turned CEO shares his strategy on buying and building a mid-size company.

Jennifer Pellet CEO Briefing Newsletter May 27 2013

The DNA of Disruptive Innovation

For the past 30 years pharma has thrived on big molecule breakthroughs and savvy marketing, but that model has been challenged by an environment of skyrocketing health care spending, rising development costs and intensifying competition from generics. Clearly, pharma needs a way to rethink its business—change its DNA—and re-invent and renew itself by rethinking the entire end-to-end value chain.

Jennifer Pellet CEO Briefing Newsletter , Leadership & Strategy July 22 2013

Free Newsletters

Sign up now to receive our free e-newsletters. You can choose to receive our weekly CEO Briefing updates, monthly Entrepreneurial CEO newsletter, and exclusive CEO surveys.